SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

BIOT-YG-I FIA Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

CRP Rapid Quantitative Test

The C-reactive protein(CRP) is synthesized by the liver in response to interleukin-6 and is well known as one of the classical acute-phase reactants. It is used as a marker of inflammation and cardiovascular diseases(C-VD). Biotime CRP test includes hs-CRP and normal CRP test parameters which has wider test range.

Dengue IgG/IgM Antibody Rapid Qualitative Test (Fluorescence Immunoassay)

The Biotime DengueIgG/IgM Antibody Rapid Testis intended to qualitatively detect the dengue IgG/IgM antibody in human serum, plasma or whole blood samples on Biotime FIA Analyzer byfluorescent immunoassay. The test is used asthe early aid diagnosis and screening of dengue virus infection. For in vitro diagnostic use only. For professional use only.

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Lp-PLA2 Rapid Quantitative Test

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that plays a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Biotime rapid quantitative test kit measures the amount or activity of Lp-PLA2 in the human blood.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay)

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A